Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Mar 20;24(3):173-181.
doi: 10.3779/j.issn.1009-3419.2021.102.09.

CTLA-4 +49 A/G Polymorphism and the Risk of Lung Cancer: a Meta-analysis

Zhengliang Wei #  1 , Shaoqin Zhang #  1 , Jian Hu  2
Affiliations
Meta-Analysis

CTLA-4 +49 A/G Polymorphism and the Risk of Lung Cancer: a Meta-analysis

Zhengliang Wei et al. Zhongguo Fei Ai Za Zhi. .

Abstract

Background: Lung cancer is one of the malignant tumors. Gene mutations associated with cellular immune function and regulating the activation and proliferation of immune cells. Several publications have explored the relationship between cytotoxic T lymphocyte antigen-4 (CTLA-4) +49 adenine (A)/guanine (G) polymorphism and susceptibility of lung cancer, but the results remain controversial. Thus, we performed this meta-analysis to derive a more comprehensive estimation of the relationship.

Methods: All articles addressed lung cancer and polymorphisms of CTLA-4 were searched from the PubMed, EMBASE databases published up to June 29, 2019. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. Publication bias of relevant studies was examined via Begg's test and funnel plots.

Results: The meta-analysis included 8 case-control studies covering 4,430 lung cancer patients and 5,198 healthy controls from September 2008 to April 2020. The overall eligible data indicated that CTLA-4 +49A/G polymorphisms did not correlate with the elevated lung cancer risk in all genetic comparison models (dominant model: OR=1.037, 95%CI: 0.925-1.161; recessive model: OR=0.968, 95%CI: 0.888-1.055; allele model: OR=0.992, 95%CI: 0.933-1.054; homozygous model: OR=0.980, 95%CI: 0.857-1.121; heterozygous model: OR=1.023, 95%CI: 0.906-1.154). In further stratified analyses, CTLA-4 +49A/G polymorphism was found to be significantly associated with susceptibility to NSCLC in these models (dominant model: OR=1.404, 95%CI: 1.074-1.836; allele model: OR=1.273, 95%CI: 1.034-1.565; homozygous model: OR=1.553, 95%CI: 1.044-2.310; heterozygous model: OR=1.308, 95%CI: 1.062-1.611).

Conclusions: CTLA-4 +49A/G polymorphism were not associated with the risk of lung cancer but might be a risk factor only in NSCLC.

Keywords: CTLA-4; Lung neoplasms; Meta-analysis; Polymorphism.

PubMed Disclaimer

Figures

1
1
Flow diagram of the study selection process
2
2
Forest plot of CTLA-4+49 A > G polymorphism and lung cancer risk in different genetic comparison models. A: dominant model; B: recessive model; C: allele model; D: homozygous model; E: heterozygous model.
3
3
Funnel plot of CTLA-4+49 A > G polymorphism and lung cancer risk in dominant model (A), recessive model (B), allele model (C), homozygous model (D), heterozygous model (E).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19. doi: 10.1007/978-3-319-24223-1_1. - DOI - PubMed
    1. Li L, Chen W, Ying W, et al. Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis. 2011;32(3):336–342. doi: 10.1093/carcin/bgq264. - DOI - PubMed
    1. Andrew AS, Nelson HH, Kelsey KT, et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis. 2006;27(5):1030–1037. doi: 10.1093/carcin/bgi284. - DOI - PubMed
    1. Visser KE, D e, Alexandra E, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24–37. doi: 10.1038/nrc1782. - DOI - PubMed
    1. Wong YK, Chang KW, Cheng CY, et al. Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med. 2010;35(1):51–54. doi: 10.1111/j.1600-0714.2005.00377.x. - DOI - PubMed